Inventor · disambiguated record
Michael Reutlinger
Also filed as: REUTLINGER MICHAEL · REUTLINGER MICHAEL ROBERT
16 granted patents·7 pending applications·22 citations·filing 2017–2024
88Inventor score
Files withHOFFMANN LA ROCHE23
Top patents by PatentIndex Score
23 records- 0186US11739095B2Substituted benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepines as GABA A GAMMA1 positive allosteric modulatorsHOFFMANN LA ROCHE·Filed 2021·Granted Aug 29, 2023·2 cites·2 claims
- 0284US10428108B2Difluoroketamide derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Oct 1, 2019·5 cites·24 claims
- 0384US9980929B2Trifluoromethylpropanamide derivativesHOFFMANN LA ROCHE·Filed 2017·Granted May 29, 2018·5 cites·26 claims
- 0483US10941147B2Bicyclic heteroaryl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Mar 9, 2021·5 cites·12 claims
- 0582US10730881B2Fused pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2019·Granted Aug 4, 2020·2 cites·13 claims
- 0676US11440915B2Triazolo-azepine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Sep 13, 2022·1 cites·13 claims
- 0774US10899766B2Bridged piperidine derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jan 26, 2021·1 cites·13 claims
- 0873US11319314B2PhenoxytriazolesHOFFMANN LA ROCHE·Filed 2017·Granted May 3, 2022·1 cites·19 claims
- 0967US2024002393A1SUBSTITUTED BENZO[f][l ,2,4JTRIAZOL0[4,3-a][l ,4JDIAZEPINES AS GABA A GAMMA! POSITIVE ALLOSTERIC MODULATORSHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1065US2024010659A1New thiadiazolopyrimidone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1165US2024002407A1Thienopyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1264US2024294543A1Cyclohepta-thieno-diazepine derivatives as gaba a gamma1 pamHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1364US2024018163A1New thiazolopyrimidinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1462US2025179092A1Pyrido[1,2-a]pyrimidin-4-one derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1558US2023124087A1Kv3 enhancers for the treatment of cognitive disordersHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1651US10669276B2Fused pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Jun 2, 2020·0 cites·24 claims
- 1750US11414420B2Pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Aug 16, 2022·0 cites·14 claims
- 1847US11001555B2Difluoroketamide derivatives as HTRA1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted May 11, 2021·0 cites·31 claims
- 1945US10870623B2Trifluoromethylpropanamide derivatives as HTRA1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Dec 22, 2020·0 cites·28 claims
- 2045US10865182B2Difluoroketamide derivatives as HtrA1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Dec 15, 2020·0 cites·28 claims
- 2144US11059858B2Difluoroketamide derivatives as HtrA1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Jul 13, 2021·0 cites·38 claims
- 2244US11014963B2Trifluoromethylpropanamide derivatives as HTRA1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted May 25, 2021·0 cites·48 claims
- 2342US10647721B2Bicyclic heteroaryl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted May 12, 2020·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Michael Reutlinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →